Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167.8 USD | -1.01% | +2.16% | +8.28% |
12:11pm | Scholz promises support for pharma sector in Germany as Merck invests | RE |
Apr. 23 | US CDC warns of harmful reactions to fake Botox injections | RE |
Evolution of the average Target Price on AbbVie Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering AbbVie Inc.
Deutsche Bank Securities | |
Barclays | |
UBS | |
Truist Securities | |
Piper Sandler | |
Morningstar | |
Wells Fargo Securities | |
Goldman Sachs | |
BMO Capital | |
Raymond James | |
William Blair & Co. | |
BofA Securities | |
HSBC | |
Morgan Stanley | |
Guggenheim | |
Argus | |
Wolfe Research | |
Atlantic Equities | |
SVB Securities LLC | |
Credit Suisse | |
Societe Generale | |
Berenberg Bank | |
JPMorgan Chase | |
Cowen | |
Redburn | |
Mizuho Securities | |
SVB Leerink | |
Daiwa Securities | |
RBC Capital Markets |
EPS Revisions
- Stock Market
- Equities
- ABBV Stock
- Consensus AbbVie Inc.